| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.95B | +2.3% |
| Cost of Revenue | $1.72B | -3.5% |
| Gross Profit | $1.23B | +11.6% |
| R&D Expense | $32.6M | +3.2% |
| SG&A Expense | $532.4M | +1.2% |
| Interest Expense | $154.3M | -0.9% |
| Pre-tax Income | $284.1M | +428.1% |
| Income Tax | $45.1M | +187.3% |
| Net Income | $239.0M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $236.2M | +8.9% |
| Accounts Receivable | $404.2M | -8.4% |
| Inventory | $781.2M | +18.8% |
| Current Assets | $1.68B | +13.5% |
| Total Assets | $4.56B | +4.9% |
| Current Liabilities | $795.0M | -3.0% |
| Long-term Debt | $3.45B | +6.7% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $147.1M | -65.8% |
| Capital Expenditures | $83.9M | -14.3% |
| Investing Cash Flow | -$98.2M | +13.9% |
| Financing Cash Flow | -$29.1M | +90.3% |
| Free Cash Flow | $63.2M | -80.9% |
| +527.3% |
| EPS (Basic) | $3.37 | +535.8% |
| EPS (Diluted) | $3.32 | +538.5% |
| Total Liabilities |
| $4.39B |
| +4.3% |
| Stockholders' Equity | $169.9M | +25.1% |